莎普爱思,603168,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 头孢克肟,4094,1976,2118,51.73%,33.17% 其他(补充),174,95,79,45.38%,1.23% 其他,2324,2650,-326,-14.04%,-5.11% 滴眼液,3707,578,3129,84.4%,49% 大输液,3458,2072,1385,40.07%,21.7% 莎普爱思,603168,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),141,35,106,75.19%,0.31% 大输液,12871,6364,6506,50.55%,19.03% 头孢克肟,12018,5894,6124,50.95%,17.91% 其他,3333,3292,41,1.22%,0.12% 滴眼液,23233,1828,21405,92.13%,62.62% 莎普爱思,603168,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 头孢克肟,6126,2981,3144,51.33%,17.86% 其他(补充),120,51,69,57.64%,0.39% 滴眼液,11717,1009,10708,91.39%,60.82% 其他,1659,1445,214,12.88%,1.21% 大输液,6797,3327,3470,51.05%,19.71% 莎普爱思,603168,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),237,90,147,62.18%,0.34% 头孢克肟,10979,5676,5303,48.3%,12.11% 大输液,14202,6544,7658,53.92%,17.48% 其他,2830,2237,593,20.95%,1.35% 滴眼液,32496,2389,30107,92.65%,68.73% 莎普爱思,603168,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 滴眼液,17059,966,16094,94.34%,65.73% 头孢克肟及其他,7029,3396,3633,51.68%,14.84% 大输液,7654,3332,4322,56.47%,17.65% 中成药,851,512,339,39.86%,1.39% 其他(补充),203,106,98,48.11%,0.4% 莎普爱思,603168,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),84,18,66,78.31%,0.09% 大输液,9333,6100,3233,34.64%,4.46% 中成药,3632,1334,2298,63.27%,3.17% 滴眼液,68527,4423,64105,93.55%,88.38% 头孢克肟及其他,12311,9478,2834,23.02%,3.91% 莎普爱思,603168,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中成药,1649,484,1165,70.62%,3.79% 大输液,3766,2999,768,20.38%,2.5% 其他(补充),43,16,28,63.99%,0.09% 滴眼液,29990,1896,28094,93.68%,91.49% 头孢克肟及其他,6237,5585,652,10.45%,2.12% 莎普爱思,603168,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),46,16,29,64.41%,0.04% 中成药,1768,908,860,48.62%,1.15% 头孢克肟及其他,12554,11628,926,7.38%,1.24% 大输液,8117,6404,1713,21.1%,2.29% 滴眼液,75388,4077,71312,94.59%,95.29% 莎普爱思,603168,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),29,19,11,36.1%,0.03% 头孢克肟及其他,5915,5368,548,9.26%,1.51% 大输液,3786,2915,871,23.01%,2.4% 滴眼液,36824,2002,34822,94.56%,96.06% 莎普爱思,603168,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 滴眼液,66389,3129,63260,95.29%,93.21% 其他(补充),40,11,29,72.94%,0.04% 头孢克肟及其他,16002,14031,1971,12.32%,2.9% 大输液,9737,7125,2611,26.82%,3.85% 莎普爱思,603168,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,5426,3724,1702,31.37%,4.79% 头孢克肟及其他,8182,7217,964,11.79%,2.71% 滴眼液,34430,1562,32867,95.46%,92.46% 其他(补充),15,3,12,79.28%,0.03% 莎普爱思,603168,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),52,4,48,92.89%,0.09% 滴眼液,50796,2700,48096,94.68%,88.94% 大输液,12381,8041,4340,35.05%,8.03% 头孢克肟及其他,13329,11735,1594,11.96%,2.95% 莎普爱思,603168,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),26,-- ,-- ,--,0% 其他,6164,5465,699,11.33%,2.59% 大输液,6311,4284,2026,32.11%,7.52% 滴眼液,25587,1359,24229,94.69%,89.89% 莎普爱思,603168,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:莎普爱思滴眼液,38719,-- ,-- ,--,0% 其中:塑瓶大输液,3903,-- ,-- ,--,0% 其中:玻瓶大输液,1087,-- ,-- ,--,0% 其中:软袋大输液,8559,-- ,-- ,--,0% 其他(补充),45,3,41,92.75%,0.1% 其他,10468,9041,1426,13.63%,3.29% 大输液,13548,8660,4888,36.08%,11.27% 滴眼液,38753,1720,37034,95.56%,85.35% 莎普爱思,603168,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:莎普爱思滴眼液,32095,-- ,-- ,--,0% 其中:塑瓶大输液,3286,-- ,-- ,--,0% 其中:玻瓶大输液,1203,-- ,-- ,--,0% 其中:软袋大输液,8419,-- ,-- ,--,0% 其他(补充),70,16,54,77.33%,0.15% 其他,9383,8261,1122,11.95%,3.08% 大输液,12908,8406,4502,34.88%,12.37% 滴眼液,32115,1402,30713,95.63%,84.4% 莎普爱思,603168,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:塑瓶大输液,3298,-- ,-- ,--,0% 其中:玻瓶大输液,1094,-- ,-- ,--,0% 其中:软袋大输液,9497,-- ,-- ,--,0% 其中:莎普爱思滴眼液,20464,-- ,-- ,--,0% 其他(补充),132,82,51,38.29%,0.19% 其他,6368,5411,957,15.03%,3.53% 大输液,13890,7420,6470,46.58%,23.86% 滴眼液,20478,842,19636,95.89%,72.42%